IVERIC bio Inc (NASDAQ:ISEE)

12.65
Delayed Data
As of Aug 19
 -0.36 / -2.77%
Today’s Change
8.37
Today|||52-Week Range
19.35
-24.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$1.6B

Company Description

IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ.

Contact Information

IVERIC bio, Inc.
8 Sylvan Way
Parsippany New Jersey 07054
P:(609) 474-6755
Investor Relations:
(212) 845-8231

Employees

Shareholders

Other institutional60.82%
Mutual fund holders35.22%
Individual stakeholders2.04%

Top Executives

Glenn P. SblendorioChief Executive Officer & Director
Pravin U. DugelPresident
Keith WestbyChief Operating Officer & Senior Vice President
David F. CarrollChief Financial Officer, Treasurer & Senior VP
Xiao Ping DaiChief Technical Officer